Elizabeth Carbajal-DiVasto

Elizabeth Carbajal-DiVasto has extensive work experience in the field of quality assurance, particularly in the pharmaceutical industry. Elizabeth'smost recent position was as Vice President of Quality at Cidara Therapeutics, where they had overall responsibility for ensuring compliance with GMP, GLP, and GCP regulations. Prior to this, they held the role of Executive Director of Quality Assurance at Cidara Therapeutics, where they led and managed the department responsible for quality strategy, systems, and policy.

Before joining Cidara Therapeutics, Carbajal-DiVasto worked as a Senior Quality Consultant at Quality Consulting, providing support to various pharmaceutical companies in developing and implementing quality systems. Elizabeth also held the position of Senior Director of Quality Assurance at Cadence Pharmaceuticals, a Mallinckrodt Company, where they oversaw quality control and compliance.

Carbajal-DiVasto's earlier experience includes roles as Director/Senior Manager of Quality Assurance at Maxim Pharmaceuticals, Senior Manager of Quality Assurance at Isis Pharmaceuticals, and Manager of Quality Assurance at La Jolla Pharmaceutical Company.

Throughout their career, Carbajal-DiVasto has demonstrated expertise in GXP practices, including pre-clinical drug development, product supply, vendor selection, and qualification. Elizabeth is also experienced in developing and delivering GXP training presentations.

Elizabeth Carbajal-DiVasto completed their Bachelor's degree in Chemistry/Biochemistry from UC San Diego, which they pursued from 1987 to 1991.